1
Back
Biodrugs cover

Biodrugs

IF6.9
Papers1574
Citations3462
Journal Papers 1667
Publication Date
Clinical Outcomes After Week-12 Response-Guided Secukinumab Discontinuation in Psoriasis: A Prospective Real-World Cohort Study
delete2026-08-03
delete0
PREAI
deleteXin Ma; Yue Jiang; Dongmei Liu; Quanruo Xu; Fanlingzi Shen; Zhen Duan; Xiangjin Gao; Xiuqi Zhang; Ruiqi Cai; Rui Zhang; Bin Li; Ruiping Wang
deleteShare
deleteSave
Population Pharmacokinetic Comparability of CT-P16 Versus EU-Avastin® and US-Avastin® in Healthy Subjects and Patients with Non-Squamous Non-Small Cell Lung Cancer
delete2026-08-02
delete0
deleteOAAI
deleteTaekyung Kim; Heungjo Kim; Hongjae Lee; Keumyoung Ahn; Taehong Park; Hyungseok Baek; Min Jung Chang
deleteShare
deleteSave
Expanding Patient Access to Advanced Therapies
delete2026-07-21
delete0
deleteOAAI
deleteElena Guillen; Ana Hidalgo-Simon
deleteShare
deleteSave
Home Infusion With Recombinant Human α-Glucosidase in Children With Pompe Disease: The Dutch Experience Over 20 Years Across the Spectrum From Classic Infantile to Late-Onset Phenotypes
delete2026-07-20
delete0
deleteOAAI
deleteImke A. M. Ditters; Hidde H. Huidekoper; Jacqueline F. Hardon; Michelle E. Kruijshaar; Ans T. van der Ploeg; Johanna M. P. van den Hout
deleteShare
deleteSave
Why Product Drift Is Not an Issue for Biosimilars/Biologics: Start the Same, Stay the Same
delete2026-07-08
delete0
deleteOAAI
deleteJoseph P. Park; Hyunhee Oh; Gillian R. Woollett
deleteShare
deleteSave
Ustekinumab Biosimilars versus Reference Ustekinumab for Moderate-to-Severe Plaque Psoriasis: A Pre-switch Systematic Review and Meta-analysis
delete2026-07-02
delete0
PREAI
deleteCarlos Roberto Montes-de-Oca-Saucedo; Laura Ghanem; Najwaa Kirmani; Bruno Briceño-Villardaga; Andrea Michelle Talancon-Solana; Adela Jatzari Salinas-Ocampo; Grecia Sereno-Acevedo; Adolfo Soto-Domínguez; Raquel Rivera-Díaz
deleteShare
deleteSave
Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials
delete2026-07-01
delete0
deleteOAAI
deleteZhihua Ran; Yan Chen; Yinglei Miao; Yufang Wang; Xiang Gao; Jie Zhong; Xueli Ding; Chengdang Wang; Xiaolan Zhang; Yijuan Ding; Naizhong Hu; Dan Tang; Jiao Yu; Chenxi Qian; Jun Shen
deleteShare
deleteSave
Gene Therapy Strategies for Uveal Melanoma: Adeno-associated Virus Delivery Challenges and Translational Opportunities
delete2026-06-25
delete0
deleteOAAI
deleteRebecca J. Wilson; Charmaine A. Ramlogan-Steel; William J. Deasy; Sarah J. Greenstein; Christopher J. Layton; Jason C. Steel
deleteShare
deleteSave
An Overview and Trend Analysis of Biosimilar Approvals in China
delete2026-06-17
delete0
PREAI
deleteMei Yang; Ning Zhang; Haixue Wang
deleteShare
deleteSave
Impact of Repeated Antigen Exposure on Humoral Tolerance: Antidrug Antibodies After Single-Dose Versus Multi-dose Adalimumab
delete2026-06-17
delete0
deleteOAAI
deleteAnika M. Valk; Jolinde van Strien; Ninotska Derksen; Dorien Kos; Júlia Castellon Teixell; Jerry Janssen; Floris C. Loeff; Lisanne Dijk; Maureen Leeuw; Catherine Smith; Teresa Tsakok; Richard Warren; Nick J. Reynolds; Christopher E. M. Griffiths; Jonathan Barker; Robert Rissman; Wouter ten Voorde; Justin Jacobse; Daniel Alvarez; Marieke van Ham; Gertjan Wolbink; Anja ten Brinke; Theo Rispens
deleteShare
deleteSave
Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field
delete2026-06-15
delete0
deleteOAAI
deleteMatthew J. Slarve; Christine Tkaczyk; Michael P. Doyle; Timothy J. Break; Alexander B. Smith; Galit Alter; Brian Luna; Brad Spellberg; Antonio DiGiandomenico
deleteShare
deleteSave
mRNA Vaccines for Influenza: Hope for a Universal Vaccine?
delete2026-06-15
delete0
PREAI
deletePriscilla Omotara; Wandi Zhu; Bao-Zhong Wang
deleteShare
deleteSave
Giving Antibiotics a Second Chance: Evolutionary Trade-Offs and Phage-Driven Restoration of Antibiotic Susceptibility
delete2026-06-12
delete0
deleteOAAI
deleteMichał Wójcicki; Martyna Cieślik; Andrzej Górski; Ewa Jończyk-Matysiak
deleteShare
deleteSave
Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage?
delete2026-06-12
delete0
deleteOAAI
deleteCapucine Arrivé; Marie Hotot; Jean-François Jourdil; Françoise Stanke-Labesque
deleteShare
deleteSave
Balancing Efficacy and Safety in Multiple Myeloma Patients Receiving B cell Maturation Antigen–Directed CAR T-Cell Therapy
delete2026-05-15
delete0
deleteOAAI
deleteMaria T. Kuipers; Jorne Migchelbrink; Anne Marijn Kramer; Mathilde C. M. Kouwenhoven; Sonja Zweegman; Kaz Groen; Niels W. C. J. van de Donk
deleteShare
deleteSave
Understanding the Therapeutic Potential of PD-1 Agonism in Inflammatory and Autoimmune Disorders
delete2026-05-13
delete0
PREAI
deleteJustin Zhong; Ruijiang Song; Nacim Kerrouche; Xinyu Yu; Yotam Levin; Adam Mor
deleteShare
deleteSave
Recombinant Protein Drugs: A 2025 Update
delete2026-05-13
delete0
deleteOAAI
deleteHèctor López-Laguna; Eloi Parladé; Marianna T. P. Favaro; Carlos Palacín; Eric Voltà-Durán; Neus Ferrer-Miralles; José Luis Corchero; Rosalía Rodríguez-Rodríguez; Esther Vázquez; Ugutz Unzueta; Antonio Villaverde
deleteShare
deleteSave
Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials
delete2026-05-12
delete0
deleteOAAI
deleteZhihua Ran; Yan Chen; Yinglei Miao; Yufang Wang; Xiang Gao; Jie Zhong; Xueli Ding; Chengdang Wang; Xiaolan Zhang; Yijuan Ding; Naizhong Hu; Dan Tang; Jiao Yu; Chenxi Qian; Jun Shen
deleteShare
deleteSave
Correction: Real-World Use of Dostarlimab Plus Chemotherapy in Advanced or Recurrent Endometrial Cancer: A Nationwide Cohort Study in France
delete2026-05-05
delete0
deleteOAAI
deleteAllison Singier; Stéphane Vignot; David Desplas; Mahmoud Zureik; Nadia Haddy
deleteShare
deleteSave